Get the Stockscreener App
22.29
4.66%
-1.09
Caredx Inc stock is traded at $22.29, with a volume of 894.49K.
It is down -4.66% in the last 24 hours and down -1.81% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
See More
Previous Close:
$23.38
Open:
$23.68
24h Volume:
894.49K
Relative Volume:
1.14
Market Cap:
$1.20B
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-8.2862
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
-9.02%
1M Performance:
-1.81%
6M Performance:
-33.18%
1Y Performance:
+170.51%
1-Day Range:
$22.24
$24.02
1-Week Range:
$22.24
$25.55
52-Week Range:
$7.42
$34.84
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
22.29 | 1.20B | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders - Business Wire
CareDx’s AlloSeq cfDNA Matches AlloSure Test Performance By Investing.com - Investing.com Nigeria
CareDx (CDNA) to Release Earnings on Wednesday - MarketBeat
CareDx, Inc. Announces Study Showing Alloseq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients - Marketscreener.com
CareDx's AlloSeq cfDNA Matches AlloSure Test Performance By Investing.com - Investing.com South Africa
CareDx's AlloSeq cfDNA Matches AlloSure Test Performance - Investing.com
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients - News Hub
Allspring Global Investments Holdings LLC Raises Stock Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
StockNews.com Downgrades CareDx (NASDAQ:CDNA) to Hold - MarketBeat
CareDX, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information - ACCESS Newswire
CareDx (NASDAQ:CDNA) Trading Down 5.5%Time to Sell? - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
CareDx (NASDAQ:CDNA) Sees Large Volume IncreaseStill a Buy? - MarketBeat
A company insider recently sold 3,512 shares of Caredx Inc [CDNA]. Should You Sale? - Knox Daily
Exploring Three High Growth Tech Stocks In The United States - Yahoo Finance
CareDx’s AlloHeme Shows Accuracy in Detecting Relapse Following AlloHSCT in AML and MDS - CGTLive™
Caredx Inc (CDNA) expanding its growth trajectory ahead - SETE News
Revolutionary Cancer Detection: CareDx Study Reveals 36-Day Early Warning System for Leukemia Relapse - StockTitan
CAREDX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CareDx, Inc.CDNA - ACCESS Newswire
CareDx (CDNA) Soars 11.2%: Is Further Upside Left in the Stock? - MSN
Market Momentum: Caredx Inc (CDNA) Registers a -8.43 Decrease, Closing at 22.81 - The Dwinnex
Investing in CareDx (NASDAQ:CDNA) a year ago would have delivered you a 187% gain - Yahoo Finance
CareDx (NASDAQ:CDNA) Trading Down 5.5% – Here’s Why - Defense World
Caredx Inc [CDNA] Stock sold by Insider Novack Jeffrey Adam for $81829.0 - Knox Daily
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results - The Bakersfield Californian
Calamos Advisors LLC Cuts Stock Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Adversity is less terrifying than hope: Caredx Inc (CDNA) - SETE News
Market Insights: Caredx Inc (CDNA)’s Notable Gain of 2.12, Closing at 23.59 - The Dwinnex
Does CareDx (CDNA) Have the Potential to Rally 42.25% as Wall Street Analysts Expect? - Yahoo Finance
Did Caredx Inc (CDNA) perform well in the last session? - US Post News
Wells Fargo upgrades Caredx Inc (CDNA) stock to an Equal weight - Knox Daily
Brokerages Set CareDx, Inc (NASDAQ:CDNA) Price Target at $28.33 - MarketBeat
SG Americas Securities LLC Purchases 5,706 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
CareDx, Inc (NASDAQ:CDNA): Are Analysts Optimistic? - Simply Wall St
CareDx, Inc (NASDAQ:CDNA) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Vanguard Group Inc. Increases Stake in CareDx Inc. - GuruFocus.com
Is CareDx (CDNA) Outperforming Other Medical Stocks This Year? - Yahoo Finance
CareDx (CDNA) Traded Down Due to Disappointing Quarterly Results - MSN
CareDx (NASDAQ:CDNA) Trading Down 5.4%Should You Sell? - MarketBeat
Here’s Why CareDx (CDNA) Traded Lower in Q4 - Insider Monkey
Leidos teams with CareDx to transform the Organ Procurement and Transplantation Network - Leidos
Best Momentum Stocks to Buy for January 21st - Yahoo Finance
Wells Fargo upgrades CareDx after a 30% pullback in stock - MSN
CareDx, Inc (NASDAQ:CDNA) Sees Significant Growth in Short Interest - MarketBeat
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
3.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):